The Therapeutic Goods Administration (TGA) has recalled 44 products containing the cough suppressant pholcodine after an investigation linked the ingredient with an increased risk of potentially fatal anaphylactic reactions to other medicines used during general anaesthesia.
The pholcodine-containing products have also been cancelled from the Australian Register of Therapeutic Goods — along with another 11 products not currently on shelves — meaning they will no longer be able to be lawfully supplied in Australia.
